Literature DB >> 18419414

Status of school entry requirements for varicella vaccination and vaccination coverage 11 years after implementation of the varicella vaccination program.

Adriana S Lopez1, Maureen S Kolasa, Jane F Seward.   

Abstract

We reviewed progress toward adoption of day care and school entry requirements in each state and the District of Columbia (DC) and compared varicella vaccination coverage by state to year of implementation of day care entry requirements. By the start of the 2006-2007 school year, 46 states (92%) and DC had implemented entry requirements for varicella vaccination. Between 1997 and 2005, national varicella vaccination coverage among children 19-35 months of age increased from 25.8% to 87.9%. Implementation of day care entry requirements in 2000 or earlier was associated with higher vaccination coverage (> or =90%; P=.002). Implementation of day care and school entry requirements for varicella vaccination is an important strategy for achieving and maintaining high vaccination coverage among preschool- and school-aged children in the United States. The newly adopted vaccine policy recommendation of 2 doses of varicella vaccine for all school-aged children should be incorporated into the states' school entry requirements.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18419414     DOI: 10.1086/522139

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Physician Knowledge and Attitudes About Hepatitis A and Current Practices Regarding Hepatitis A Vaccination Delivery.

Authors:  Noele P Nelson; Mandy A Allison; Megan C Lindley; Michaela Brtnikova; Lori A Crane; Brenda L Beaty; Laura P Hurley; Allison Kempe
Journal:  Acad Pediatr       Date:  2017-01-09       Impact factor: 3.107

2.  The effect of policy changes on hepatitis A vaccine uptake in Arizona children, 1995-2008.

Authors:  Kacey C Ernst; Kristen Pogreba-Brown; Lisa Rasmussen; Laura M Erhart
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

Review 3.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

4.  Parental Hesitancy About Routine Childhood and Influenza Vaccinations: A National Survey.

Authors:  Allison Kempe; Alison W Saville; Christina Albertin; Gregory Zimet; Abigail Breck; Laura Helmkamp; Sitaram Vangala; L Miriam Dickinson; Cindy Rand; Sharon Humiston; Peter G Szilagyi
Journal:  Pediatrics       Date:  2020-06-15       Impact factor: 7.124

5.  Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine.

Authors:  Barbara A Pahud; Carol A Glaser; Cornelia L Dekker; Ann M Arvin; D Scott Schmid
Journal:  J Infect Dis       Date:  2010-12-21       Impact factor: 5.226

6.  Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor.

Authors:  Zhen Zhang; Anca Selariu; Charles Warden; Grace Huang; Ying Huang; Oluleke Zaccheus; Tong Cheng; Ningshao Xia; Hua Zhu
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

7.  Upgrading the school entry vaccination record check strategy to improve varicella vaccination coverage: results from a quasi-experiment study.

Authors:  Wei Qin; Jian Song; Yao Wang; Tingyue Nie; Fan Pan; Xiaokang Xu; Hailin Tao; Xiangmei Meng; Ruyu Ni; Shishi Cheng; Shaoyu Xie; Hong Su
Journal:  Hum Vaccin Immunother       Date:  2021-05-21       Impact factor: 3.452

8.  Joining the herd? U.S. public opinion and vaccination requirements across educational settings during the COVID-19 pandemic.

Authors:  Simon F Haeder
Journal:  Vaccine       Date:  2021-03-23       Impact factor: 3.641

9.  Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011.

Authors:  Andrea Streng; Veit Grote; David Carr; Christine Hagemann; Johannes G Liese
Journal:  BMC Infect Dis       Date:  2013-07-02       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.